DexCom Shares Outstanding 2011-2025 | DXCM
DexCom shares outstanding history from 2011 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
- DexCom shares outstanding for the quarter ending September 30, 2025 were 0.407B, a 0.68% decline year-over-year.
- DexCom 2024 shares outstanding were 0.413B, a 3.01% decline from 2023.
- DexCom 2023 shares outstanding were 0.426B, a 0.47% decline from 2022.
- DexCom 2022 shares outstanding were 0.428B, a 0.3% decline from 2021.
|
DexCom Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024 | 413 |
| 2023 | 426 |
| 2022 | 428 |
| 2021 | 429 |
| 2020 | 420 |
| 2019 | 369 |
| 2018 | 353 |
| 2017 | 345 |
| 2016 | 334 |
| 2015 | 319 |
| 2014 | 301 |
| 2013 | 284 |
| 2012 | 275 |
| 2011 | 262 |
| 2010 | 228 |
|
DexCom Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025-09-30 | 407 |
| 2025-06-30 | 408 |
| 2025-03-31 | 408 |
| 2024-12-31 | 413 |
| 2024-09-30 | 410 |
| 2024-06-30 | 417 |
| 2024-03-31 | 417 |
| 2023-12-31 | 426 |
| 2023-09-30 | 427 |
| 2023-06-30 | 432 |
| 2023-03-31 | 419 |
| 2022-12-31 | 428 |
| 2022-09-30 | 426 |
| 2022-06-30 | 421 |
| 2022-03-31 | 429 |
| 2021-12-31 | 429 |
| 2021-09-30 | 430 |
| 2021-06-30 | 427 |
| 2021-03-31 | 418 |
| 2020-12-31 | 420 |
| 2020-09-30 | 398 |
| 2020-06-30 | 388 |
| 2020-03-31 | 376 |
| 2019-12-31 | 369 |
| 2019-09-30 | 370 |
| 2019-06-30 | 364 |
| 2019-03-31 | 361 |
| 2018-12-31 | 353 |
| 2018-09-30 | 361 |
| 2018-06-30 | 358 |
| 2018-03-31 | 349 |
| 2017-12-31 | 345 |
| 2017-09-30 | 347 |
| 2017-06-30 | 350 |
| 2017-03-31 | 341 |
| 2016-12-31 | 334 |
| 2016-09-30 | 336 |
| 2016-06-30 | 334 |
| 2016-03-31 | 328 |
| 2015-12-31 | 319 |
| 2015-09-30 | 322 |
| 2015-06-30 | 318 |
| 2015-03-31 | 311 |
| 2014-12-31 | 301 |
| 2014-09-30 | 304 |
| 2014-06-30 | 301 |
| 2014-03-31 | 293 |
| 2013-12-31 | 284 |
| 2013-09-30 | 286 |
| 2013-06-30 | 284 |
| 2013-03-31 | 279 |
| 2012-12-31 | 275 |
| 2012-09-30 | 276 |
| 2012-06-30 | 274 |
| 2012-03-31 | 271 |
| 2011-12-31 | 262 |
| 2011-09-30 | 270 |
| 2011-06-30 | 260 |
| 2011-03-31 | 249 |
| 2010-12-31 | 228 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $22.644B | $4.033B |
| DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $217.426B | 25.83 |
| Intuitive Surgical (ISRG) | United States | $196.986B | 77.07 |
| IDEXX Laboratories (IDXX) | United States | $55.092B | 54.71 |
| Edwards Lifesciences (EW) | United States | $50.080B | 33.58 |
| Alcon (ALC) | Switzerland | $38.300B | 25.88 |
| IQVIA Holdings (IQV) | United States | $37.570B | 20.95 |
| Mettler-Toledo (MTD) | United States | $28.663B | 33.53 |
| STERIS (STE) | Ireland | $25.362B | 26.18 |
| Waters (WAT) | United States | $22.587B | 29.87 |
| Hologic (HOLX) | United States | $16.492B | 17.36 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.115B | 0.00 |
| Globus Medical (GMED) | United States | $11.303B | 23.72 |
| Penumbra (PEN) | United States | $10.968B | 77.15 |
| Masimo (MASI) | United States | $8.117B | 26.01 |
| Sysmex ADR (SSMXY) | Japan | $6.351B | 20.18 |
| Glaukos (GKOS) | United States | $5.171B | 0.00 |
| Teleflex (TFX) | United States | $4.729B | 7.54 |
| TransMedics (TMDX) | United States | $3.930B | 46.56 |
| Veracyte (VCYT) | United States | $3.111B | 35.45 |
| LivaNova (LIVN) | United Kingdom | $3.023B | 16.33 |
| Alphatec Holdings (ATEC) | United States | $2.932B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.435B | 11.43 |
| Artivion (AORT) | United States | $2.165B | 99.35 |
| Nihon Kohden (NHNKY) | Japan | $2.021B | 17.64 |
| Elekta AB (EKTAY) | Sweden | $1.737B | 16.83 |
| PROCEPT BioRobotics (PRCT) | United States | $1.659B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.262B | 0.00 |
| Beta Bionics (BBNX) | United States | $1.197B | 0.00 |
| AxoGen (AXGN) | United States | $1.086B | 0.00 |
| IRadimed (IRMD) | United States | $1.073B | 51.12 |
| OPKO Health (OPK) | United States | $0.983B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.976B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.915B | 4.96 |
| SiBone (SIBN) | United States | $0.756B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.592B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.529B | 30.78 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.529B | 10.55 |
| AngioDynamics (ANGO) | United States | $0.499B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.486B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.439B | 0.00 |
| NeuroPace (NPCE) | United States | $0.431B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.419B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.408B | 11.27 |
| RxSight (RXST) | United States | $0.400B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.376B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.331B | 2.49 |
| Delcath Systems (DCTH) | United States | $0.315B | 52.53 |
| Alpha Tau Medical (DRTS) | Israel | $0.315B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.295B | 0.00 |
| CVRx (CVRX) | United States | $0.243B | 0.00 |
| 908 Devices (MASS) | United States | $0.198B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.193B | 0.00 |
| Inogen (INGN) | United States | $0.187B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.187B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.152B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.147B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.139B | 0.00 |
| Neuronetics (STIM) | United States | $0.136B | 0.00 |
| LENSAR (LNSR) | United States | $0.121B | 0.00 |
| Accuray (ARAY) | United States | $0.118B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.103B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.094B | 0.00 |
| Hyperfine (HYPR) | United States | $0.090B | 0.00 |
| InspireMD (NSPR) | United States | $0.089B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.079B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.075B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.071B | 0.00 |
| Spectral AI (MDAI) | United States | $0.047B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.045B | 0.00 | |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.027B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.019B | 0.00 |
| Envoy Medical (COCH) | United States | $0.017B | 0.00 |
| NexGel (NXGL) | United States | $0.016B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.012B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.012B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.008B | 0.00 |
| Solana (HSDT) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.24 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |